Search / 21 results found

from
to
  • Updated

SEATTLE, Nov. 22, 2021 /PRNewswire/ -- OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders, today announced that Clifford Stocks, Chief Executive Officer, will participate in two upcoming investor conferences.